← Scroll for more →
Financial Statements — FBDT
Balance Sheet
(in millions USD)| Metric | Q4 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q1 2025 | Q4 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|
| Accounts Receivable | 0.05 | 0.03 | -- | 0.05 | -- | 0.03 | -- |
| Inventory | -- | 0.79 | -- | 0.92 | -- | 1.85 | -- |
| Total Current Assets | -- | 6.99 | -- | 3.49 | -- | 2.35 | -- |
| Property, Plant & Equipment | -- | 6.01 | -- | 6.46 | -- | 7.36 | -- |
| Total Non-current Assets* | -- | 10.63 | -- | 9.53 | -- | 11.15 | -- |
| Total Assets | -- | 17.62 | -- | 13.02 | -- | 13.51 | -- |
| Accounts Payable | -- | 1.32 | -- | 2.04 | -- | 1.85 | -- |
| Total Current Liabilities | -- | 15.23 | -- | 4.63 | -- | 3.96 | -- |
| Long-term Debt | -- | -- | -- | 0.03 | -- | -- | -- |
| Total Non-current Liabilities* | -- | 1.02 | -- | 1.99 | -- | 4.44 | -- |
| Total Liabilities | -- | 16.25 | -- | 6.62 | -- | 8.40 | -- |
| Retained Earnings | -- | (63.77) | -- | (35.24) | -- | (21.42) | -- |
| Total Stockholder Equity | -- | 1.37 | 6.10 | 6.40 | 3.70 | 5.11 | 9.75 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | 0.10 | -- | 0.10 | -- |
| Cost of Revenue | 0.61 | -- | 0.59 | -- |
| Gross Profit | (0.51) | -- | (0.80) | -- |
| Research & Development | 0.13 | -- | -- | -- |
| Selling, General & Admin | 11.20 | -- | 0.87 | -- |
| Total Operating Expenses | 11.33 | -- | 0.87 | -- |
| Operating Income | (11.84) | -- | (1.67) | -- |
| Pretax Income | (13.88) | -- | (2.24) | -- |
| Net Income | (13.88) | (14.65) | (2.24) | (1.57) |
| Basic EPS | (0.26) | -- | (0.06) | -- |
| Diluted EPS | (0.26) | -- | (0.06) | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | (5.76) |
| Investing Cash Flow | (1.68) |
| Financing Cash Flow | 9.89 |
← Scroll for more columns →